Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

NCT06519994 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus
Human Papillomavirus
Cervical Precancer

Interventions

DRUG: Artesunate vaginal inserts
DRUG: Placebo vaginal inserts

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]